Literature DB >> 17400713

Vascular endothelial growth factor-C stimulates the lymphatic pump by a VEGF receptor-3-dependent mechanism.

Jerome W Breslin1, Nathalie Gaudreault, Katherine D Watson, Rashell Reynoso, Sarah Y Yuan, Mack H Wu.   

Abstract

Vascular endothelial growth factor (VEGF)-C plays an important role in lymphangiogenesis; however, functional responses of lymphatic vessels to VEGF-C have not been characterized. We tested the hypothesis that VEGF-C-induced activation of VEGF receptor (VEGFR)-3 increases lymphatic pump output. We examined the in vivo pump activity of rat mesenteric collecting lymphatics using intravital microscopy during basal conditions and during treatment with 1 nM recombinant VEGF-C, the selective VEGFR-3 agonist VEGF-Cys(156)Ser mutation (C156S; 1 nM), or 0.1 nM VEGF-A. Their specific responses were also analyzed during selective inhibition of VEGFR-3 with MAZ-51. Contraction frequency, end-diastolic diameter, end-systolic diameter, stroke volume index, pump flow index, and ejection fraction were evaluated. We also assessed arteriolar diameter and microvascular extravasation of FITC-albumin. The results show that both VEGF-C and VEGF-C156S significantly increased contraction frequency, end-diastolic diameter, stroke volume index, and pump flow index in a time-dependent manner. VEGF-A caused a different response characterized by a significantly increased stroke volume after 30 min of treatment. MAZ-51 (5 muM) caused tonic constriction and decreased contraction frequency. In addition, 0.5 and 5 muM MAZ-51 attenuated VEGF-C- and VEGF-C156S-induced lymphatic pump activation. VEGF-A caused vasodilation of arterioles, whereas VEGF-C and VEGF-C156S did not significantly alter arteriolar diameter. Also, VEGF-A and VEGF-C caused increased microvascular permeability, whereas VEGF-C156S did not. Our results demonstrate that VEGF-C increases lymphatic pumping through VEGFR-3. Furthermore, changes in microvascular hemodynamics are not required for VEGFR-3-mediated changes in lymphatic pump activity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17400713     DOI: 10.1152/ajpheart.00102.2007

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  44 in total

1.  Role of vascular and lymphatic endothelial cells in hantavirus pulmonary syndrome suggests targeted therapeutic approaches.

Authors:  Erich R Mackow; Elena E Gorbunova; Nadine A Dalrymple; Irina N Gavrilovskaya
Journal:  Lymphat Res Biol       Date:  2013-09-11       Impact factor: 2.589

2.  Impaired lymphatic contraction associated with immunosuppression.

Authors:  Shan Liao; Gang Cheng; David A Conner; Yuhui Huang; Raju S Kucherlapati; Lance L Munn; Nancy H Ruddle; Rakesh K Jain; Dai Fukumura; Timothy P Padera
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-07       Impact factor: 11.205

Review 3.  Lymphatic function and immune regulation in health and disease.

Authors:  Shan Liao; Timothy P Padera
Journal:  Lymphat Res Biol       Date:  2013-09-11       Impact factor: 2.589

4.  Adaptation of mesenteric collecting lymphatic pump function following acute alcohol intoxication.

Authors:  Flavia M Souza-Smith; Kristine M Kurtz; Patricia E Molina; Jerome W Breslin
Journal:  Microcirculation       Date:  2010-10       Impact factor: 2.628

5.  Impaired Peripheral Lymphatic Function and Cerebrospinal Fluid Outflow in a Mouse Model of Alzheimer's Disease.

Authors:  Sunkuk Kwon; Ines Moreno-Gonzalez; Kathleen Taylor-Presse; George Edwards Iii; Nazaret Gamez; Olivia Calderon; Banghe Zhu; Fred Christian Velasquez; Claudio Soto; Eva M Sevick-Muraca
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

6.  Altered lymphatic function and architecture in salt-induced hypertension assessed by near-infrared fluorescence imaging.

Authors:  Sunkuk Kwon; Germaine D Agollah; Wenyaw Chan; Eva M Sevick-Muraca
Journal:  J Biomed Opt       Date:  2012-08       Impact factor: 3.170

7.  Estimation of the Pressure Drop Required for Lymph Flow through Initial Lymphatic Networks.

Authors:  David C Sloas; Scott A Stewart; Richard S Sweat; Travis M Doggett; Natascha G Alves; Jerome W Breslin; Donald P Gaver; Walter L Murfee
Journal:  Lymphat Res Biol       Date:  2016-06-06       Impact factor: 2.589

8.  Dual-channel in-situ optical imaging system for quantifying lipid uptake and lymphatic pump function.

Authors:  Timothy Kassis; Alison B Kohan; Michael J Weiler; Matthew E Nipper; Rachel Cornelius; Patrick Tso; J Brandon Dixon
Journal:  J Biomed Opt       Date:  2012-08       Impact factor: 3.170

9.  An interstitial hypothesis for breast cancer related lymphoedema.

Authors:  David O Bates
Journal:  Pathophysiology       Date:  2009-12-05

10.  Lymphangiogenic therapy prevents cardiac dysfunction by ameliorating inflammation and hypertension.

Authors:  LouJin Song; Xian Chen; Terri A Swanson; Brianna LaViolette; Jincheng Pang; Teresa Cunio; Michael W Nagle; Shoh Asano; Katherine Hales; Arun Shipstone; Hanna Sobon; Sabra D Al-Harthy; Youngwook Ahn; Steven Kreuser; Andrew Robertson; Casey Ritenour; Frank Voigt; Magalie Boucher; Furong Sun; William C Sessa; Rachel J Roth Flach
Journal:  Elife       Date:  2020-11-17       Impact factor: 8.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.